Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2015.10.29
第三届董事会第十八次会议决议公告
2015.10.29
关于公司使用自有资金购买低风险理财产品的公告
2015.10.29
关于向控股子公司提供委托贷款的公告
2015.10.29
第三届监事会第十三次会议决议公告
2015.10.20
关于签订《募集资金三方监管协议》的公告
2015.10.20
关于控股子公司创新药物获得I期临床试验备案的公告
2015.10.14
关于公司使用自有资金购买低风险理财产品的进展公告
2015.10.12
关于新增募集资金专项存储账户的公告
2015.10.12
华英证券有限责任公司关于公司使用部分超募资金对外投资的核查意见
2015.10.12
第三届监事会第十二次会议决议公告
第一页
上一页
98
99
100
101
102
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
